274 related articles for article (PubMed ID: 8611394)
1. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.
Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B
Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394
[TBL] [Abstract][Full Text] [Related]
2. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
3. Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.
Holló Z; Homolya L; Hegedûs T; Müller M; Szakács G; Jakab K; Antal F; Sarkadi B
Anticancer Res; 1998; 18(4C):2981-7. PubMed ID: 9713496
[TBL] [Abstract][Full Text] [Related]
4. Calcein accumulation as a fluorometric functional assay of the multidrug transporter.
Holló Z; Homolya L; Davis CW; Sarkadi B
Biochim Biophys Acta; 1994 May; 1191(2):384-8. PubMed ID: 7909692
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
6. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
7. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
Hu Z; Zhou Z; Hu Y; Wu J; Li Y; Huang W
PLoS One; 2015; 10(2):e0116886. PubMed ID: 25689592
[TBL] [Abstract][Full Text] [Related]
8. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
9. Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference.
Ansbro MR; Shukla S; Ambudkar SV; Yuspa SH; Li L
PLoS One; 2013; 8(4):e60334. PubMed ID: 23593196
[TBL] [Abstract][Full Text] [Related]
10. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
[TBL] [Abstract][Full Text] [Related]
11. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
[TBL] [Abstract][Full Text] [Related]
12. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
13. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.
Holló Z; Homolya L; Hegedüs T; Sarkadi B
FEBS Lett; 1996 Mar; 383(1-2):99-104. PubMed ID: 8612802
[TBL] [Abstract][Full Text] [Related]
14. Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity.
Laupeze B; Amiot L; Courtois A; Vernhet L; Drenou B; Fauchet R; Fardel O
Int J Oncol; 1999 Sep; 15(3):571-6. PubMed ID: 10427142
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells.
Wielinga PR; Heijn M; Broxterman HJ; Lankelma J
Biochem Pharmacol; 1997 Oct; 54(7):791-9. PubMed ID: 9353133
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells.
Utoguchi N; Chandorkar GA; Avery M; Audus KL
Reprod Toxicol; 2000; 14(3):217-24. PubMed ID: 10838122
[TBL] [Abstract][Full Text] [Related]
17. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
18. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
Quesada AR; García Grávalos MD; Fernández Puentes JL
Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
[TBL] [Abstract][Full Text] [Related]
19. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
[TBL] [Abstract][Full Text] [Related]
20. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]